ON-DEMAND WEBINAR
Modernizing the Clinical Data Flow: Operating Models, Governance & Architectures for Scalable Clinical Flow
Date: Wednesday, 11 March 2026
Time: 3.30 PM to 4.30 PM IST
About the webinar
As global tax agencies adapt to new pressures, leaders in tax compliance, fraud prevention and administration face increasingly complex challenges.
From combating sophisticated tax evasion schemes to managing data governance and advanced AI, tax administrators must embrace innovation to meet regulatory demands and improve taxpayer services.
In this exclusive webinar, SAS experts dive into the top five trends impacting tax agencies in 2025.
Learn how emerging challenges and opportunities, informed by insights from the OECD and the Federation of Tax Administrators, are shaping the future of tax policy and operations.
Whether you’re focused on audit, collections or advanced analytics, gain practical strategies to navigate these transformative changes.
We will discuss:
- Operating Model & Governance
- Reducing the ‘Status Quo’ Barrier
- Accelerators & Repeatable Assets
- Personas & Change Management
- Security‑by‑Design & Agentic Workflows
- Migration Patterns
- Reference Architecture for SAS Viya on AWS 🙂
About the experts
Daniel Hickmore
Senior Strategy Leader – Europe Health and Life Sciences Industry R&D, AWS
Daniel Hickmore is a senior strategy leader at AWS specializing in the Life Sciences sector. Daniel has more than 20 years of experience, engaging with global pharmaceutical, biotechnology and R&D organizations, including AstraZeneca, Johnson & Johnson, and Novo Nordisk
Over the years, Daniel has developed a deep expertise in designing and executing strategic roadmaps for cloud transformation, AI/ML, and Generative AI within Life Sciences R&D.
Parag Limaye
Managing Director, Deloitte Consulting
Parag is a leader in Deloitte’s Life Sciences practice, specializing in the R&D domain. His primary focus is on spearheading modernization programs and architecting innovative solutions to enhance data management capabilities across the industry.
He has led several large-scale transformational projects, developing platforms to extract value from historical clinical trial data, omics, RWD, and other data modalities. Additionally, he oversees the development of Deloitte’s internal hybrid assets, which help clients accelerate their journey to derive value from existing data
Dr. Mark Lambrecht
Senior Director, Global Healthcare and Life Sciences, SAS
Dr. Mark Lambrecht has more than 20 years of experience studying and implementing the potential, use and future of analytics, artificial intelligence and data engineering to advance patient outcomes. He is responsible for the global health care and life sciences market strategy of SAS. Mark likes to discuss how leaders in government, hospitals, payers and pharmaceutical manufacturers can take AI, real world evidence and digital healthcare from hype to reality, without oversimplifying clinical, financial and operational complexity.
Prior to joining SAS, Mark worked in the pharmaceutical industry and studied at the KU Leuven, Belgium and at Stanford University, USA. He holds a PhD and Master in Bioscience Genetic Engineering from the KU Leuven.
Mark Lambrecht is an expert in the application of AI, analytics and data engineering to the healthcare and life sciences sector, and particularly how technology can improve patient outcomes.